SCHEMBL13332007

SCHEMBL13332007

CCc1ccc(C(=O)OC)c(C(=O)OC)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
GAA P10253 4/20 0.56
KDM4E B2RXH2 4/20 0.56
MAPT P10636 3/20 0.56
HPGD P15428 3/20 0.56
HSD17B10 Q99714 2/20 0.56
TSHR P16473 2/20 0.56
ALOX15 P16050 1/20 0.56
CA12 O43570 2/20 0.48
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
CA7 P43166 2/20 0.48
CA9 Q16790 2/20 0.48
CA14 Q9ULX7 2/20 0.48
PDK2 Q15119 1/20 0.48
PDK4 Q16654 1/20 0.48
NPSR1 Q6W5P4 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
GLA P06280 1/20 0.46
CASP1 P29466 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24529103 0.88 ALDH1A1 (0.49) ALDH1A1GAAKDM4EMAPTHPGD
SCHEMBL26270868 0.87 MAPT (0.51) ALDH1A1GAAKDM4EMAPTHPGD
SCHEMBL6477497 0.86 CA12 (0.55) ALDH1A1GAAKDM4EMAPTHPGD
SCHEMBL607262 0.86 ALDH1A1 (0.50) ALDH1A1GAAKDM4EMAPTHPGD
SCHEMBL30822769 0.86 ALDH1A1 (0.44) ALDH1A1GAAKDM4EMAPTHPGD
SCHEMBL17201140 0.85 CA12 (0.65) ALDH1A1GAAKDM4EMAPTHPGD
SCHEMBL9582728 0.85 GAA (0.53) ALDH1A1GAAKDM4EMAPTHPGD
SCHEMBL29943277 0.85 ALDH1A1 (0.53) ALDH1A1GAAKDM4EMAPTHPGD
SCHEMBL5502090 0.85 ALDH1A1 (0.49) ALDH1A1GAAKDM4EMAPTHPGD
SCHEMBL1022658 0.85 ALDH1A1 (0.53) ALDH1A1GAAKDM4EMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240207429-A1 LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME WILMINGTON TRUST, NATIONAL ASSOCIATION 2024-06-27 US disclosed
US-8372516-B2 (Meth)acrylate phosphonic esters as adhesion promoters BASF SE (DE) 2013-02-12 US disclosed
US-8367743-B2 Adhesion promoting photoinitiators for UV cured coatings over metal surfaces BASF SE (DE) 2013-02-05 US disclosed
US-20100112362-A1 (METH)ACRYLATE PHOSPHONIC ESTERS AS ADHESION PROMOTERS CIBA CORPORATION (US) 2010-05-06 US disclosed
US-20090104464-A1 Adhesion promoting photoinitiators for UV cured coatings over metal surfaces IGM GROUP B.V. (NL) 2009-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240207429-A1 LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME PAICS, DHFR, CD44 ALDH1A1 820/4885GAA 1776/4885KDM4E 2160/4885
US-20090104464-A1 Adhesion promoting photoinitiators for UV cured coatings over metal surfaces CDH1, PCNA, VCAM1 ALDH1A1 302/4885GAA 2304/4885KDM4E 749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.